drug · small molecule
minoxidil ER
Phase 3updated 6mo agoby $MANE Veradermics, Inc🔗 ChEMBL
Phase 3community read0 votes
🐶 often sniffed alongside
top 4Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for hypertension and hypotrichosis and 5 investigational indications.
targets
Sulfonylurea receptor 2, Kir6.2
all catalysts(0)
nothing on the calendar yet
Trials studying minoxidil ER
- phase3Efficacy and Safety of 5% Minoxidil Foam in Female Androgenetic Alopecia
- phase3Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia
- N/AEffects of a Topical Serum Solution on Hair Characteristics
- phase3Efficacy & Safety of Minoxidil SL Tablets in Men With AGA
- phase3Phase 3 Study to Evaluate the Efficacy and Safety of Oral Minoxidil (N1087) in Men With Androgenetic Alopecia.
- phase3Androgenic Alopecia TH07 Clinical Trial
- phase2Clinical Trial to Evaluate CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia
- phase3Efficacy and Safety of Finlândia Hair Lotion Association on Androgenetic Alopecia
News(10)
- Disc’s redemption, China’s rise, Veradermics’ validation, ESMO’s headlinersChina cracks down on some biotechnology ownership transfers—but will the new policy impact licensing deals?; Disc Medicine’s Phase 3 data sweep redeems rejected rare disease therapy, teeing up anot…biospace · 29d ago
- Roche inks $15B ADC pact with Hansoh; Veradermics scores in another baldness studyRoche is paying Hansoh $400 million up front in a broad deal involving several ADCs. Elsewhere, another top investor formed a China-focused fund and Ultragenyx sold a second review voucher.biopharma_dive · 1mo ago
- Veradermics’ minoxidil pill improves hair coverage in men in Phase 3In the wake of a successful IPO and strong stock growth throughout the year, Veradermics now has late-stage data to support a regulatory package for its hair loss pill.biospace · 1mo ago
- Veradermics' oral Rogaine wins again at growing hair in late-stage trialVeradermics is taking another victory lap with its oral twist on minoxidil, commonly known as Rogaine. The Connecticut biotech said VDPHL01, its extended-release version of the decades-old hair-reg…endpoints · 1mo ago
- Veradermics keeps ‘momentum going’ as baldness drug helps women with hair lossThe Phase 2 data exceeded expectations, lifting company shares as high as nearly $130 apiece and building the case for what may be the first pill specifically approved for female pattern hair loss.biopharma_dive · 4mo ago
- STAT+: Celcuity’s breast cancer drug approved, its firstFDA's new CBER chief promises normalcy, an weight loss drug without GLP-1s, and more biotech news from The Readoutstat · 4mo ago
- Veradermics declares first efficacy win in women for hair loss drugVeradermics is for the first time reporting positive efficacy of its oral formulation of minoxidil in female pattern hair loss, which broadens the market potential of its flagship asset. In a mid-s…endpoints · 4mo ago
- Veradermics soars on positive data for baldness treatmentThe results could support the first approval in decades for an oral medicine that can treat male pattern baldness, though the therapy will face competition from generics and over-the-counter medica…biopharma_dive · 6mo ago
- STAT+: Astellas retries XLMTM gene therapy after deathsVeradermics' hair loss pill late-stage trial success, FDA fast-tracks reviews for psychedelics, and more biotech newsstat · 6mo ago
- Veradermics wins at growing hair with oral Rogaine in first key test as a public companyVeradermics has succeeded in its first major test as a newly-minted public company. The biotech's form of oral Rogaine cleared the bar in a Phase 2/3 trial in men with mild-to-moderate pattern hair…endpoints · 6mo ago
Data sources
last refreshed 6h ago
Found something off?
comments(0)
5-min edit window · permanent after that